Playback speed
10 seconds
Trastuzumab Deruxtecan for HER2+ MBC With Brain Mets: DESTINY-Breast01 Trial Subgroup Analysis
661 views
August 12, 2021
Comments 1
Login to view comments.
Click here to Login